DD299062A5 - Verwendung von pteridinen und verfahren zu deren herstellung - Google Patents
Verwendung von pteridinen und verfahren zu deren herstellung Download PDFInfo
- Publication number
- DD299062A5 DD299062A5 DD89333128A DD33312889A DD299062A5 DD 299062 A5 DD299062 A5 DD 299062A5 DD 89333128 A DD89333128 A DD 89333128A DD 33312889 A DD33312889 A DD 33312889A DD 299062 A5 DD299062 A5 DD 299062A5
- Authority
- DD
- German Democratic Republic
- Prior art keywords
- group
- methyl
- morpholino
- propyl
- pteridine
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D475/00—Heterocyclic compounds containing pteridine ring systems
- C07D475/06—Heterocyclic compounds containing pteridine ring systems with a nitrogen atom directly attached in position 4
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D475/00—Heterocyclic compounds containing pteridine ring systems
- C07D475/06—Heterocyclic compounds containing pteridine ring systems with a nitrogen atom directly attached in position 4
- C07D475/08—Heterocyclic compounds containing pteridine ring systems with a nitrogen atom directly attached in position 4 with a nitrogen atom directly attached in position 2
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE3833393A DE3833393A1 (de) | 1988-10-01 | 1988-10-01 | Verwendung von pteridinen zur verhinderung der primaeren und sekundaeren resistenz bei der chemotherapie und diese verbindungen enthaltende arzneimittel |
Publications (1)
Publication Number | Publication Date |
---|---|
DD299062A5 true DD299062A5 (de) | 1992-03-26 |
Family
ID=6364156
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DD89333128A DD299062A5 (de) | 1988-10-01 | 1989-09-29 | Verwendung von pteridinen und verfahren zu deren herstellung |
Country Status (19)
Country | Link |
---|---|
EP (1) | EP0362645B1 (hu) |
JP (1) | JPH02256676A (hu) |
KR (1) | KR910006289A (hu) |
AT (1) | ATE106728T1 (hu) |
AU (1) | AU620645B2 (hu) |
DD (1) | DD299062A5 (hu) |
DE (2) | DE3833393A1 (hu) |
DK (1) | DK480489A (hu) |
ES (1) | ES2056174T3 (hu) |
FI (1) | FI92699C (hu) |
HU (1) | HU205761B (hu) |
IL (1) | IL91814A (hu) |
MX (1) | MX9203034A (hu) |
NO (1) | NO175979C (hu) |
NZ (1) | NZ230833A (hu) |
PT (1) | PT91836B (hu) |
SU (1) | SU1720491A3 (hu) |
UA (1) | UA8028A1 (hu) |
ZA (1) | ZA897414B (hu) |
Families Citing this family (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2000039129A1 (en) * | 1998-12-28 | 2000-07-06 | K.U. Leuven Research & Development | Immunosuppressive effects of pteridine derivatives |
US7276506B2 (en) | 1998-12-28 | 2007-10-02 | 4 Aza Bioscience Nv | Immunosuppressive effects of pteridine derivatives |
DE10202468A1 (de) * | 2002-01-23 | 2004-09-30 | Faustus Forschungs Cie. Translational Cancer Research Gmbh | Pteridinderivate, Verfahren zu deren Herstellung und ihre Verwendung |
WO2005025574A2 (en) * | 2003-09-12 | 2005-03-24 | 4 Aza Bioscience Nv | PTERIDINE DERIVATIVES FOR THE TREATMENT OF SEPTIC SHOCK AND TNF-α-RELATED DISEASES. |
WO2005039587A1 (en) * | 2003-10-17 | 2005-05-06 | 4 Aza Bioscience Nv | Heterocycle-substituted pteridine derivatives and their use in therapy |
RU2447074C2 (ru) * | 2005-05-12 | 2012-04-10 | Тиботек Фармасьютикалз Лтд. | Птеридины, полезные в качестве ингибиторов hcv, и способы получения птеридинов |
US10144736B2 (en) | 2006-07-20 | 2018-12-04 | Gilead Sciences, Inc. | Substituted pteridines useful for the treatment and prevention of viral infections |
EP3722297A1 (en) | 2015-03-04 | 2020-10-14 | Gilead Sciences, Inc. | Toll-like receptor modulating 4,6-diamino-pyrido[3,2-d]pyrimidine compounds |
KR20160003575A (ko) | 2015-11-09 | 2016-01-11 | 정민시 | 발전기용 동력전달장치 |
WO2018045150A1 (en) | 2016-09-02 | 2018-03-08 | Gilead Sciences, Inc. | 4,6-diamino-pyrido[3,2-d]pyrimidine derivaties as toll like receptor modulators |
AU2017318601B2 (en) | 2016-09-02 | 2020-09-03 | Gilead Sciences, Inc. | Toll like receptor modulator compounds |
TWI751517B (zh) | 2019-04-17 | 2022-01-01 | 美商基利科學股份有限公司 | 類鐸受體調節劑之固體形式 |
TW202210480A (zh) | 2019-04-17 | 2022-03-16 | 美商基利科學股份有限公司 | 類鐸受體調節劑之固體形式 |
TW202115056A (zh) | 2019-06-28 | 2021-04-16 | 美商基利科學股份有限公司 | 類鐸受體調節劑化合物的製備方法 |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3574206A (en) * | 1965-04-15 | 1971-04-06 | Boehringer Sohn Ingelheim | 2,7-dimorpholino-4-amino-6-phenyl-pteridines |
NL129630C (hu) * | 1966-10-14 | |||
DE1617336C2 (de) * | 1966-11-25 | 1982-07-01 | C.H. Boehringer Sohn, 6507 Ingelheim | Arzneimittel gegen Angina pectoris |
DE1795515A1 (de) * | 1967-08-18 | 1972-03-30 | Thomae Gmbh Dr K | Verfahren zur Herstellung von neuen Pteridinen |
DE1795516A1 (de) * | 1967-12-15 | 1972-01-27 | Thomae Gmbh Dr K | 4-AEthanolisopropanolamino-2-(2'-methylmorpholino)-7-morpholino-6-phenyl-pteridin |
DE1921308A1 (de) * | 1969-04-25 | 1971-01-07 | Boehringer Sohn Ingelheim | Herzwirksame Zubereitungen |
US4767761A (en) * | 1987-11-04 | 1988-08-30 | Dana-Farber Cancer Institute, Inc. | Ornithine derivatives and their use as methotrexate-resistant cell inhibitors |
-
1988
- 1988-10-01 DE DE3833393A patent/DE3833393A1/de not_active Withdrawn
-
1989
- 1989-09-23 AT AT89117610T patent/ATE106728T1/de not_active IP Right Cessation
- 1989-09-23 ES ES89117610T patent/ES2056174T3/es not_active Expired - Lifetime
- 1989-09-23 DE DE58907824T patent/DE58907824D1/de not_active Expired - Fee Related
- 1989-09-23 EP EP89117610A patent/EP0362645B1/de not_active Expired - Lifetime
- 1989-09-26 AU AU41749/89A patent/AU620645B2/en not_active Ceased
- 1989-09-28 IL IL9181489A patent/IL91814A/en not_active IP Right Cessation
- 1989-09-28 PT PT91836A patent/PT91836B/pt not_active IP Right Cessation
- 1989-09-29 ZA ZA897414A patent/ZA897414B/xx unknown
- 1989-09-29 HU HU895131A patent/HU205761B/hu not_active IP Right Cessation
- 1989-09-29 JP JP1255126A patent/JPH02256676A/ja active Pending
- 1989-09-29 SU SU894742036A patent/SU1720491A3/ru active
- 1989-09-29 UA UA4742036A patent/UA8028A1/uk unknown
- 1989-09-29 NZ NZ230833A patent/NZ230833A/en unknown
- 1989-09-29 NO NO893879A patent/NO175979C/no unknown
- 1989-09-29 FI FI894615A patent/FI92699C/fi not_active IP Right Cessation
- 1989-09-29 DD DD89333128A patent/DD299062A5/de not_active IP Right Cessation
- 1989-09-29 DK DK480489A patent/DK480489A/da not_active Application Discontinuation
- 1989-09-29 KR KR1019890014002A patent/KR910006289A/ko not_active Application Discontinuation
-
1992
- 1992-06-19 MX MX9203034A patent/MX9203034A/es unknown
Also Published As
Publication number | Publication date |
---|---|
PT91836B (pt) | 1995-07-18 |
HU205761B (en) | 1992-06-29 |
EP0362645A3 (de) | 1992-03-25 |
PT91836A (pt) | 1990-04-30 |
MX9203034A (es) | 1992-07-01 |
NO893879D0 (no) | 1989-09-29 |
AU620645B2 (en) | 1992-02-20 |
NZ230833A (en) | 1991-05-28 |
ATE106728T1 (de) | 1994-06-15 |
HUT52504A (en) | 1990-07-28 |
FI92699C (fi) | 1994-12-27 |
DK480489A (da) | 1990-04-02 |
FI894615A0 (fi) | 1989-09-29 |
ES2056174T3 (es) | 1994-10-01 |
FI92699B (fi) | 1994-09-15 |
DE58907824D1 (de) | 1994-07-14 |
IL91814A (en) | 1994-02-27 |
DE3833393A1 (de) | 1990-04-05 |
NO893879L (no) | 1990-04-02 |
EP0362645B1 (de) | 1994-06-08 |
UA8028A1 (uk) | 1995-12-26 |
JPH02256676A (ja) | 1990-10-17 |
NO175979C (no) | 1995-01-11 |
NO175979B (no) | 1994-10-03 |
FI894615A (fi) | 1990-04-02 |
EP0362645A2 (de) | 1990-04-11 |
SU1720491A3 (ru) | 1992-03-15 |
ZA897414B (en) | 1991-06-26 |
KR910006289A (ko) | 1991-04-29 |
IL91814A0 (en) | 1990-06-10 |
DK480489D0 (da) | 1989-09-29 |
AU4174989A (en) | 1990-04-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP1599478B1 (de) | Dihydropteridinone, verfahren zu deren herstellung und deren verwendung als arzneimittel | |
DE69823648T2 (de) | 1-phenyl-4-benzylpiperazine: spezifische liganden für den dopamin rezeptor (d4) | |
DD299062A5 (de) | Verwendung von pteridinen und verfahren zu deren herstellung | |
EP2176266A2 (de) | Substituierte imidazo[1,2b]pyridazine als kinase-inhibitoren, deren herstellung und verwendung als arzneimittel | |
DE60302221T2 (de) | Heteroaryl substituierte 2-pyridinyl und 2-pyrimidinyl-6,7,8,9-tetrahydropyrimido[1,2-a]pyrimidin-4-onderivate | |
CN108069946B (zh) | 具有穿过血脑屏障能力的取代的喹唑啉化合物 | |
JPS5865267A (ja) | スルホンアミド誘導体、その製法及びそれを含む医薬組成物 | |
CH616677A5 (hu) | ||
EP1632493A1 (de) | Dihydropteridinonderivative, Verfahren zu deren Herstellung und deren Verwendung als Arzneimittel | |
DE60103909T2 (de) | 2-pyridinyl-6,7,8,9-tetrahydropyrimido[1,2-a]pyrimidin-4-on- und 7-pyridinyl-2,3-dihydroimidazo[1,2-a]pyrimidin-5 1honderivate | |
DE69533194T2 (de) | PYRAZOLO(3,4-g)CHINOXALINE ALS PDGF-REZEPTOR PROTEIN TYROSIN-KINASE INHIBITOREN | |
DE19636769A1 (de) | 3-Substituierte Pyrido [4',3':4,5]thieno[2,3-d]pyrimidin-Derivate, ihre Herstellung und Verwendung | |
DE10202468A1 (de) | Pteridinderivate, Verfahren zu deren Herstellung und ihre Verwendung | |
DE19756036A1 (de) | Amid- und Harnstoffderivate | |
DD295088A5 (de) | Verwendung von aryl-substituierten aminderivaten zur herstellung von arzneimitteln und verfahren zu ihrer herstellung | |
US5932593A (en) | Piperidine derivatives and anti-platelet agents containing the same | |
DE60104130T2 (de) | 1-(alkyl), 1-[(heteroaryl)alkyl] und 1-[(aryl)alkyl]-7-pyridinyl-imidazo[1,2-a]pyrimidin-5(1h)-onderivate | |
EP0645390A1 (de) | Trisubstituierte Pyrimido/5,4-d/-pyrimidine zur Modulation der Multidrugresistenz, diese Verbindungen enthaltende Arzneimittel und Verfahren zu ihrer Herstellung | |
DE69612753T2 (de) | (r)-5-bromo-n-(1-ethyl-4-methylhexahydro-1h-1,4-diazepin-6-yl)-2-methoxy-6-methylamino-3-pyridincarboxamid, verfahren zu seinerherstellung und dieses enthaltende medizinische zubereitung | |
CH643549A5 (de) | N-(trimethoxybenzyl)-n'-phenylpiperazine. | |
DE4009941A1 (de) | Verwendung von pteridinen zur sensibilisierung resistenter plasmodien bei der malaria-chemotherapie und diese verbindungen enthaltende arzneimittel | |
DE2753791C2 (hu) | ||
EP0589908B1 (de) | Aminoalkylsubstituierte thiazolin-2-one, ihre herstellung und verwendung | |
US5098902A (en) | Method of treating neurodegenerative diseases | |
DE4225353A1 (de) | Neue Pteridine, diese Verbindungen enthaltende Arzneimittel und Verfahren zu ihrer Herstellung |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
ENJ | Ceased due to non-payment of renewal fee |